1. Home
  2. |Insights
  3. |Claim Construction Under the BRI Standard: Can An "Incorrect" Interpretation Still Be "Reasonable"?

Claim Construction Under the BRI Standard: Can An "Incorrect" Interpretation Still Be "Reasonable"?

Client Alert | less than 1 min read | 04.14.20

Insights

Client Alert | 16 min read | 08.13.25

The new EU “Pharma Package”: Access conditionalities and Shortage measures – A comparison of Commission/Parliament/Council positions

In this seventh alert in our weekly series on the Pharma Package, we will discuss the increasing focus on shortages of medicinal products in the EU and the prevention and mitigation measures as proposed by the European Commission, the European Parliament and the Council of the EU....